KEIAH HUNT: Open Payments
NPI 1982938205 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 43 payments from 12 companies in 2025. Trend: 2023 $1,131 · 2024 $998 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $240 |
| Vanda Pharmaceuticals Inc. | 6 | $154 |
| Otsuka America Pharmaceutical, Inc. | 5 | $146 |
| Neurocrine BioSciences, Inc. | 6 | $133 |
| Tris Pharma Inc | 5 | $89 |
| Lundbeck LLC | 4 | $76 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| ABBVIE INC. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
Products named: Auvelity, INGREZZA, FANAPT, ABILIFY MAINTENA, Dyanavel XR, REXULTI, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across AR — which companies pay providers there.
